Comparing reproductive outcomes between conventional in vitro fertilization and nonindicated intracytoplasmic sperm injection in autologous embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System Study.

Autor:	Gingold JA; Montefiore Institute for Reproductive Medicine and Health, OB/GYN & Women's Health, Hartsdale, New York., Wu H; Mailman School of Public Health, Columbia University, New York, New York., Lieman H; Montefiore Institute for Reproductive Medicine and Health, OB/GYN & Women's Health, Hartsdale, New York., Singh M; Montefiore Institute for Reproductive Medicine and Health, OB/GYN & Women's Health, Hartsdale, New York., Jindal S; Montefiore Institute for Reproductive Medicine and Health, OB/GYN & Women's Health, Hartsdale, New York.
Jazyk:	angličtina
Zdroj:	F&S reports [F S Rep] 2023 Oct 29; Vol. 5 (1), pp. 23-32. Date of Electronic Publication: 2023 Oct 29 (Print Publication: 2024).
DOI:	10.1016/j.xfre.2023.10.004
Abstrakt:	Objective: To compare clinical outcomes between nonindicated intracytoplasmic sperm injection (ICSI) and conventional insemination. Design: Autologous cycles performed from 2014-2017 were identified, excluding frozen oocyte cycles. Outcomes were compared between conventional insemination (in vitro fertilization [IVF]) and nonindiated ICSI and analyzed separately for fresh, frozen-thawed preimplantation genetic testing (PGT) and frozen-thawed non-PGT cycles. Setting: US-based fertility clinics reporting to the Society for Assisted Reproductive Technology. Participants: A total of 187,520 patients underwent 318,930 cycles, 57,516 (18.0%) using conventional IVF and 261,414 ICSI (82.0%). Interventions: Intracytoplasmic sperm injection, with or without indications (male factor, prior fertilization failure or any PGT [2012 recommendations]/single-gene PGT [2020 recommendations]). Main Outcome Measures: Odds ratios (ORs) for live birth rates and clinical pregnancy rates were calculated after multivariable adjustment for maternal age, body mass index, infertility etiologies, prior IVF births, and number oocytes retrieved. Results: Intracytoplasmic sperm injection was indicated in 151,627 (58.0%) of cycles according to 2012 American Society for Reproductive Medicine Practice Committee recommendations, and 108,895 (41.7%) according to 2020 recommendations. In multivariable models, nonindicated ICSI among fresh cycles was associated with reduced odds of completing a blastocyst-stage transfer (OR, 0.72; 95% confidence interval [CI] [0.7, 0.75]; P <.001), resulting in reduced odds of live birth (OR, 0.80; 95% CI [0.78, 0.83]; P <.001). Among completed fresh transfers, clinical pregnancy and live birth rates were comparable between nonindicated ICSI and IVF. Nonindicated ICSI in frozen-thawed cycles with PGT and without PGT was associated with comparable live birth and clinical pregnancy rates with IVF in multivariable models. Conclusion: Nonindicated ICSI was associated with reduced blastocyst availability in fresh cycles compared with IVF, leading to lower live birth rates. Outcomes from completed transfers were clinically comparable. Competing Interests: J.A.G. has nothing to disclose. H.W. has nothing to disclose. H.L. has nothing to disclose. M.S. has nothing to disclose. S.J. has nothing to disclose. (© 2023 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu